1218 related articles for article (PubMed ID: 19668124)
21. Transplantation for hilar cholangiocarcinoma.
Heimbach JK; Haddock MG; Alberts SR; Nyberg SL; Ishitani MB; Rosen CB; Gores GJ
Liver Transpl; 2004 Oct; 10(10 Suppl 2):S65-8. PubMed ID: 15382214
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis.
Grimsrud MM; Folseraas T
Liver Int; 2019 Dec; 39(12):2230-2237. PubMed ID: 31216595
[TBL] [Abstract][Full Text] [Related]
23. Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma.
Wu Y; Johlin FC; Rayhill SC; Jensen CS; Xie J; Cohen MB; Mitros FA
Liver Transpl; 2008 Mar; 14(3):279-86. PubMed ID: 18306329
[TBL] [Abstract][Full Text] [Related]
24. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.
Patel AH; Harnois DM; Klee GG; LaRusso NF; Gores GJ
Am J Gastroenterol; 2000 Jan; 95(1):204-7. PubMed ID: 10638584
[TBL] [Abstract][Full Text] [Related]
25. An update on cholangiocarcinoma associated with primary sclerosing cholangitis.
Fevery J; Verslype C
Curr Opin Gastroenterol; 2010 May; 26(3):236-45. PubMed ID: 20216413
[TBL] [Abstract][Full Text] [Related]
26. Cholangioscopy to screen for cholangiocarcinoma in primary sclerosing cholangitis.
Caldwell SH; Bickston SJ
Liver Transpl; 2001 Apr; 7(4):380. PubMed ID: 11303302
[No Abstract] [Full Text] [Related]
27. Bile duct brushings for the early detection of cholangiocarcinoma.
Jamidar P
J Clin Gastroenterol; 2006 Apr; 40(4):279-80. PubMed ID: 16633096
[No Abstract] [Full Text] [Related]
28. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
Ehlken H; Schramm C
Dig Dis; 2013; 31(1):118-25. PubMed ID: 23797133
[TBL] [Abstract][Full Text] [Related]
29. Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases.
Layfield LJ; Cramer H
Diagn Cytopathol; 2005 Feb; 32(2):119-24. PubMed ID: 15637668
[TBL] [Abstract][Full Text] [Related]
30. Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen?
de Groen PC
Hepatology; 2000 Jan; 31(1):247-8. PubMed ID: 10613754
[No Abstract] [Full Text] [Related]
31. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
Song J; Li Y; Bowlus CL; Yang G; Leung PSC; Gershwin ME
Clin Rev Allergy Immunol; 2020 Feb; 58(1):134-149. PubMed ID: 31463807
[TBL] [Abstract][Full Text] [Related]
32. Sclerosing cholangitis.
MacFaul GR; Chapman RW
Curr Opin Gastroenterol; 2006 May; 22(3):288-93. PubMed ID: 16550044
[TBL] [Abstract][Full Text] [Related]
33. Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Fevery J; Verslype C; Lai G; Aerts R; Van Steenbergen W
Dig Dis Sci; 2007 Nov; 52(11):3123-35. PubMed ID: 17431781
[TBL] [Abstract][Full Text] [Related]
34. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.
Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN
Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis.
Bangarulingam SY; Bjornsson E; Enders F; Barr Fritcher EG; Gores G; Halling KC; Lindor KD
Hepatology; 2010 Jan; 51(1):174-80. PubMed ID: 19877179
[TBL] [Abstract][Full Text] [Related]
36. Diagnosing cholangiocarcinoma in primary sclerosing cholangitis: an "evidence based radiology" review.
Walker SL; McCormick PA
Abdom Imaging; 2008; 33(1):14-7. PubMed ID: 17874262
[TBL] [Abstract][Full Text] [Related]
37. Characteristic Features of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis.
Ishii Y; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Chayama K
Hepatogastroenterology; 2014 May; 61(131):567-73. PubMed ID: 26176037
[TBL] [Abstract][Full Text] [Related]
38. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
[TBL] [Abstract][Full Text] [Related]
39. Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
Njei B; McCarty TR; Varadarajulu S; Navaneethan U
Gastrointest Endosc; 2017 Apr; 85(4):773-781.e10. PubMed ID: 27590963
[TBL] [Abstract][Full Text] [Related]
40. The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy.
Weismüller TJ; Wedemeyer J; Kubicka S; Strassburg CP; Manns MP
J Hepatol; 2008; 48 Suppl 1():S38-57. PubMed ID: 18304683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
